首页|期刊导航|河北中医药学报|加减半夏白术天麻汤治疗痰湿阻络型抑郁症的临床疗效观察

加减半夏白术天麻汤治疗痰湿阻络型抑郁症的临床疗效观察OA

Therapeutic Effect of Modified Banxia Baizhu Tianma Decoction on Depression of Phlegm-Damp Blocking Collaterals Syndrome

中文摘要英文摘要

目的:评价加减半夏白术天麻汤治疗痰湿阻络型轻中度抑郁症的临床疗效及对炎症因子的影响.方法:纳入2025年1月至2026年1月于新疆医科大学附属中医医院神志病科诊断为痰湿阻络型轻中度抑郁症患者132例,随机分为对照组与观察组,每组各66例.对照组口服艾司西酞普兰片,观察组在对照组基础上联合加减半夏白术天麻汤口服,疗程4周.比较2组治疗前后汉密尔顿抑郁量表-24项(HAMD-24)、匹兹堡睡眠质量指数(PSQI)、中医症状积分及血清白细胞介素-1β(IL-1β)、白细胞介素-18(IL-18)、肿瘤坏死因子-α(TNF-α)水平变化,并评估临床疗效及安全性.结果:观察组临床疗效优于对照组(P<0.05).2组患者治疗后总分及体质量、日夜变化评分较治疗前均下降(P<0.05),且观察组均低于对照组(P<0.05);焦虑躯体化、认知障碍评分与治疗前比较差异无统计学意义(P>0.05).2组患者治疗后PSQI总分及各因子分,中医证候总分及各因子分,血清IL-1β、IL-18、TNF-α水平,较治疗前均下降(P<0.05),且观察组均低于对照组(P<0.05).治疗后2组血清谷丙转氨酶(ALT)、谷草转氨酶(AST)、尿素(BUN)、肌酐(CREA)水平与治疗前比较差异无统计学意义(P>0.05).结论:加减半夏白术天麻汤联合艾司西酞普兰可改善患者抑郁症状、睡眠质量及中医证候,其机制可能与抑制炎症因子表达有关,安全性良好.

Objective:To evaluate the clinical efficacy of modified Banxia Baizhu Tianma Decoction in the treatment of mild-to-moderate depression with phlegm-damp blocking collaterals syndrome and its influence on inflammatory factors.Methods:A total of 132 patients diagnosed with mild-to-moderate depression of phlegm-damp blocking collaterals syndrome in the Department of Mental Diseases,Traditional Chinese Medicine Hospital Affiliated to Xinjiang Medical University from January 2025 to January 2026 were en-rolled and randomly divided into a control group and an observation group,with 66 cases in each group.The control group was given oral escitalopram,while the observation group was additionally treated with oral modified Banxia Baizhu Tianma Decoction on the basis of the control group,with a treatment course of 4 weeks.The changes in Hamilton Depression Scale-24 items(HAMD-24),Pittsburgh Sleep Quality Index(PSQI),TCM symptom scores,as well as serum levels of interleukin-1β(IL-1β),interleukin-18(IL-18)and tumor necrosis factor-α(TNF-α)were compared between the two groups before and after treatment,and the clinical efficacy and safety were evaluated.Results:After treatment,the total scores of HAMD,PSQI and TCM symptoms,as well as partial related inflammatory factors in the ob-servation group were lower than those in the control group(P<0.05).The decreasing amplitudes of serum IL-1β,IL-18 and TNF-α in the observation group were larger than those in the control group(P<0.05).The clinical efficacy of the observation group was superior to that of the control group(P<0.05).There was no statistically significant difference in liver and renal function between the two groups(P>0.05).Conclusion:Combined application of modified Banxia Baizhu Tianma Decoction and escitalopram can relieve depressive symptoms,improve sleep quality and TCM syndromes in patients.Its therapeutic mechanism may be related to inhibiting the expression of inflammatory factors,with favorable safety profile.

常春雷;花锐;陈婷婷;尤念炼;张静;褚洪涛;陈俊逾

新疆医科大学第四临床医学院,新疆维吾尔自治区 乌鲁木齐 830063乌鲁木齐市中医医院,新疆维吾尔自治区 乌鲁木齐 830063乌鲁木齐市中医医院,新疆维吾尔自治区 乌鲁木齐 830063新疆维吾尔自治区中西医结合医院,新疆维吾尔自治区 乌鲁木齐 830011新疆医科大学第四临床医学院,新疆维吾尔自治区 乌鲁木齐 830063新疆医科大学第四临床医学院,新疆维吾尔自治区 乌鲁木齐 830063新疆医科大学第四临床医学院,新疆维吾尔自治区 乌鲁木齐 830063

医药卫生

加减半夏白术天麻汤痰湿阻络型抑郁症炎症因子临床研究

Modified Banxia Baizhu Tianma Decoctionphlegm-damp blocking collaterals syndromedepressioninflammatory factorsclinical research

《河北中医药学报》 2026 (4)

50-56,7

国家自然科学基金委员会地区科学基金项目(82260915)新疆维吾尔自治区自然科学基金面上项目(2022D01C160)

评论